Related Experiment Video
Updated: Jul 21, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Cost-benefits of vaccination programmes
1Department of Medical Economics, University Hospital, Rämistrasse 100, CH-8091, Zurich, Switzerland.
Vaccine
|February 23, 2000
Summary
Economic evaluations like cost-benefit and cost-effectiveness analysis guide healthcare resource allocation. Cost-utility analysis, using quality-adjusted life years (QALYs), compares interventions, aiding vaccination program planning and vaccine decision-making.
Area of Science:
- Health Economics
- Public Health Policy
- Vaccinology
Background:
- Healthcare resource allocation demands robust economic data.
- Key economic evaluation tools include cost-benefit, cost-effectiveness, and cost-utility analyses.
- Cost-utility analysis utilizes quality-adjusted life years (QALYs) for broad intervention comparison.
Purpose of the Study:
- To delineate the application of different economic evaluation methods in healthcare decision-making.
- To explore the utility of cost-utility analysis for vaccination program planning.
- To differentiate the optimal use of cost-benefit versus cost-effectiveness analysis for public health and recommended vaccines.
Main Methods:
- Review and synthesis of economic evaluation methodologies.
- Application of cost-utility analysis principles to vaccination programs.
- Comparative analysis of cost-benefit and cost-effectiveness approaches for vaccine assessment.
Main Results:
- Cost-effectiveness analysis aids in optimizing resource use within allocated budgets.
- Cost-benefit analysis informs broader resource allocation decisions.
- Cost-utility analysis, via QALYs, enables direct comparison of diverse medical interventions, including vaccinations.
- Combinations of vaccines offer significant economic benefits through reduced costs and improved coverage.
Conclusions:
- Appropriate economic evaluation tools are crucial for effective healthcare resource allocation.
- Cost-utility analysis is valuable for comparing childhood vaccinations and planning programs.
- Public health vaccines benefit from cost-benefit analysis, while recommended vaccines are better suited for cost-effectiveness analysis.
- Vaccination programs can achieve substantial cost-savings and economic advantages.
Related Concept Videos
01:51Vaccinations
Overview
01:26Methods Of Healthcare Delivery System
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.